DigitalHealth.London Insider
Posted on
DH.L Insider
The Week – 11th July – 15th July
As well as SME’s and clinical entrepreneurs, DigitalHealth.London is well placed to support and work with larger corporates, to assist them in navigating the NHS and/ or identifying target partners [smaller innovator companies] to collaborate and partner with. We had the privilege of presenting the DH.L vision and offer to some of the members of EMIG [Ethical Medicines Industry Group]. Digital health technology used effectively by pharma can increase patient activation and engagement channelling investment into one or more of the following enabling areas. 1) Clinical tools, 2) Smart devices, 3) Patient tools, 4) Customer insights, 5) Commissioner/ sponsor analytics or 6) Community & personalised content. Pharma can use digital health technology to leverage their deep disease expertise and marketing capabilities. A great example of this, often quoted is MSD for Mothers, a $500 million 10 year commitment programme by MSD which delivers a combination of digital interventions to mothers in 30 countries including India, Senegal, Uganda, the U.S., and Zambia. This programme aims to expand expectant and new mothers’ access to affordable, quality care.
The same advice that we give to SME’s can be applied to pharma companies. Start with the problem first, the technology comes second. Get closer to you patients and source more specific information about your customers to identify the solutions and experiences—not just the products and drugs.
Yinka Makinde
@YMakinde1
Related content
DigitalHealth.London Spotlight: CyberLiver
Every week, we shine a spotlight on one of our DigitalHealth.London companies, founders, or NHS fellows. Today, to commemorate World Liver Day, we are excited to feature our current DigitalHealth.London Accelerator company CyberLiver.
Bridging Gaps in Women’s Health: The Rise of FemTech Innovation
As innovations in FemTech continue to evolve, the future of women’s health holds promise for improved equity and accessibility. In this blog, Lavinia Pamparau, NHS Navigator for DigitalHealth.London, delves into how FemTech solutions tackle prevailing health disparities and empower women to proactively manage their health and well-being.
Getting FemTech into the NHS
FemTech has the potential to tackle health inequalities related to gender and improve the quality of life for millions of women in the UK. But, to achieve maximum impact, FemTech needs to be fully integrated into NHS pathways and services. In this blog, NHS Navigator for DigitalHealth.London Yasmin Stinchcombe explores how FemTech innovators can successfully engage with the NHS.
